The Cutting Edge
November 2004  
Cover Page
In The Industry
Are Your Clients Properly Insured?

-----------------

Disclaimer Planning

-----------------

IRS Clarifies Disability Taxation

-----------------

Buy-Sell Planning and Transfer-for-Values Issues
Tools of the Trade
Life Needs Analysis

-----------------

Human Life Value

-----------------

Agent Sales Corner





Found something interesting? Want to let someone else know about it? Simply click the "Tell A Friend" link!!

Tell A Friend
What's Happening
AM Best Company

-----------------

The Weather Channel

-----------------

Associated Press
Chronic Obstructive Pulmonary Disease
by Prudential Financial

Chronic obstructive pulmonary disease is a degenerative disorder of the lungs in which there is a reduced ability to expire air. COPD includes a combination of lung diseased such as asthma, chronic bronchitis, and emphysema.

Chronic obstructive pulmonary disease affects at least 15 million Americans. The majority of people diagnosed with COPD can be directly related to former heavy or current cigarette use. However, not all who smoke get COPD. Obstructive lung disease develops in 10-15% of all cigarette smokers and individuals who continue to smoke cigarettes are more likely to sustain a rapid progression of the disease than non-smokers.

The most accurate method of diagnosing COPD is the pulmonary function test, otherwise known as a spirometry test. It measures the amount of forced air exhaled into a tube. FEV1 is the maximum amount of air exhaled during the first second of a forced exhalation. The results help determine the severity of the COPD for the underwriter. The average non-smoking adult shows a decline in FEV1 of 20-25 ml per year whereas the average heavy smoker declines 40-45 ml per year.

For underwriting purposes, it is imperative to determine the severity of COPD by having the ability to review the results of a spirometry test. COPD is classified into four groups: mild, moderate, severe, and extreme. The chart below helps define each group of COPD by symptoms, medication, %FEV1 compared to normal, and includes the expected rating class.

 

Degree

 

Symptoms

 

Rx

 

FEV1

 

Rating

Mild

None-except for occasional throat clearing and respiratory infection

None

60-80%

B

Moderate

Airway obstruction on moderate exertion such as climbing two flights of stairs

Inhaler

50-60%

D

Severe

Shortness of breath with activity such as dressing, walking one block

Steroids, multiple medications

40-50%

G

Extreme

Disabled, shortness of breath at rest or minimal activity

Home oxygen

<40%

Decline


These rating schedules relate to individuals who have been diagnosed with COPD and have discontinued cigarettes.
[PRINTER FRIENDLY VERSION]
LETTERS

There are no letters for this article. To post your own letter, click Post Letter.

[POST LETTER]
Published by American Brokerage Services, Inc.
Copyright © 2004 American Brokerage Services, Inc.. All rights reserved.
For agent/registered representative use only. Not for public distribution.
TELL A FRIEND
Powered by IMN